Jun 24 |
Recursion Pharmaceuticals: More Of A TechBio Industrializing Drug Discovery
|
Jun 17 |
Recursion Pharmaceuticals: Unprecedented Scale
|
Jun 14 |
Recursion Pharmaceuticals: Catalysts Are Coming And Success Is A Must
|
Jun 13 |
3 Stocks Under $10 Set to Quadruple by 2025: June Edition
|
Jun 8 |
Nvidia Owns These 4 Stocks. Here’s How They’re Doing.
|
Jun 7 |
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
|
Jun 5 |
Nvidia’s Golden Handshake: 3 Stocks Reaping the Rewards of an NVDA Alliance
|
Jun 3 |
Cathie Wood Owns These 2 AI Stocks. Should You?
|
Jun 2 |
Is Recursion Pharmaceuticals Stock a Millionaire-Maker?
|
May 31 |
Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)
|